We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Medical Robotics Market to Reach USD 20 Billion by 2022

By HospiMedica International staff writers
Posted on 20 Sep 2017
The global medical robotics market is expected to grow at a CAGR of 21.6%from USD 6.36 billion in 2016 to USD 20.56 billion by 2022, driven by the enhancement of automation technologies, rising incidence of disabilities in human beings and growing baby boomer population, that impede their day-to-day physical motions.

These are the latest findings of Research and Markets (Dublin, Ireland), a global market research company.
Medical robots are used by surgeons to gain greater access to areas under operation using more detailed and less invasive methods. More...
They are present in most telemanipulators, which use the surgeon's actions on one side and to control the "effector" on the other side.

Currently, the demand for medical robots is driven by the rapidly growing demand for precise and efficient minimally invasive surgeries, although the high cost of surgery, negative publicity, and wariness among people continue to pose a challenge to the market growth. The neurology segment is expected to register the fastest growth in the medical robots market during the forecast period, driven by the advent of newer applications in neurosurgery and the growing popularity of robotic neurosurgery.

In 2016, North America held the highest share of the global medical robotics market, due to the high adoption rate of medical robots in the region and the government's strong focus on medical robots to improve the quality of healthcare. The medical robotic systems market in Asia Pacific is expected to grow at the fastest rate during the forecast period due to the availability of untapped market opportunities.

Related Links:
Research and Markets


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.